Cart
sales@molnova.com
BML-278
BML-278
Catalog No. M37061
BML-278 is a SIRT1 activator with an EC150 of 1 μM. It increases H3K9 methylation and inhibits H3K9 acetylation in parental and maternal prokaryotes, improving early embryonic development.
| Size | Price / USD | Stock | Quantity |
| 5MG | 55 | Get Quote |
|
| 10MG | 86 | Get Quote |
|
| 25MG | 153 | Get Quote |
|
| 50MG | 229 | Get Quote |
|
| 100MG | 302 | Get Quote |
|
| 500MG | 666 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBML-278
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Adamkova K, et al. SIRT1-dependent modulation of methylation and acetylation of histone H3 on lysine 9 (H3K9) in the zygotic pronuclei improves porcine embryo development. J Anim Sci Biotechnol. 2017 Nov 1;8:83.?
molnova catalog
related products
-
SirReal2 (b)
SirReal2 (MZ25) is a novel potent, selective Sirt2 inhibitor with IC50 of 0.435 uM.
-
SIRT2-IN-9
SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research.
-
SRTCX1002
SRTCX1002 (SRTCX-1002) is a small molecule activator of SIRT1 (STAC) with EC1.5 of 0.4 uM.
